News & Blog

Nov. 4, 2025—A growing number of funders and researchers are testing a new way to accelerate discovery—focused research organizations (FROs). Designed to develop essential scientific tools and data infrastructure within a time-bounded window, FROs fill a gap between traditional academic research and market-driven innovation by addressing bottlenecks in infrastructure/tools/data that existing organizations do not address.

Conventional research funding often rewards publications and incremental advances but provides little support for open, tool-building efforts that benefit the broader scientific ecosystem. FROs seek to change that equation by combining features of academia, philanthropy, and start-up culture to tackle well-defined, high-impact challenges.

The model originated in the United States, supported by philanthropic investors such as Eric Schmidt, the former chief executive of Google. Convergent Research, a U.S.-based nonprofit, has launched eight FROs since 2021. The approach is now expanding internationally, with new initiatives in the United Kingdom and early conversations in continental Europe.

Model Description

Each FRO operates as a small, full-time team of 15–30 researchers with budgets of roughly $30–50 million. Teams focus exclusively on building open, scalable tools, software, datasets, or experimental platforms that can remove scientific bottlenecks—projects typically last five years, freeing researchers from the constraints of traditional grant cycles and publication pressures.

Recent examples include:

• Imprint, mapping immune-system memory signatures to uncover mechanisms behind chronic disease.
• [C]Worthy, creating tools to measure how much carbon dioxide the ocean absorbs to support climate-change mitigation strategies.
• EvE Bio, identifying unintended drug-target interactions to help repurpose existing pharmaceuticals.

Operational Insights

FROs adopt a start-up mindset, characterized by clear deliverables, regular progress reviews, and shared goals. Team members work collaboratively on a single research question rather than individual projects. This approach introduces a project management discipline and accountability that are rarely found in academic labs.

Yet a fixed (e.g., five-year) timeline brings challenges. Some projects may require longer to achieve impact, and the limited duration complicates career continuity for participating scientists. Leaders acknowledge that not every FRO will succeed and view that as a necessary feature of innovation.

Funding sources are diversifying. While philanthropy remains central, government agencies are beginning to participate. The U.K.’s first FRO, Bind, launched this year with support from both government and private donors to map drug-binding possibilities for disordered proteins linked to cancer and dementia.

Why It Matters

For university and industry collaborators, FROs present a potential bridge between academic research and commercial development. By explicitly addressing opportunities for which other mechanisms are insufficient, they can accelerate discovery in areas where incentives for traditional funding are weak. FROs can also be focused on areas of public good that complement commercial advances.

Efforts such as UIDP’s Strengthen and Modernize U-I Partnerships (SAMI) initiative similarly help institutions and partners identify critical research capabilities and infrastructure gaps that limit innovation potential. Together, these approaches highlight the growing emphasis on mapping and addressing systemic barriers to collaborative discovery.

FROs also demonstrate how flexible, mission-driven teams can complement long-term institutional research programs. Their model of concentrated effort, open outcomes, and rapid iteration may inform future university–industry consortia or joint research initiatives. As global competition for innovation leadership intensifies, FROs provide a real-world experiment in aligning funding, focus, and speed.

Exploring What’s Next

The rise of FROs raises an important question for research stakeholders: What scientific capabilities are currently lacking, and how can universities, industry partners, and funders collaborate to develop them? As this model gains traction in the U.S. and U.K., its outcomes will help determine whether focused, time-bound research organizations can sustainably strengthen the broader innovation ecosystem.

We want to hear from you. How might universities and industry partners work together to pilot focused research organizations that bridge the gap between foundational science and applied innovation? Let us know on LinkedIn.

The 3-Minute Read is a UIDP member information piece and does not represent the opinions of our members or representatives. We welcome your comments on our LinkedIn profile.